DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Software
Updated 1d ago
CD5 logo

Inuvo, Inc.DB:CD5 Stock Report

Market Cap €8.3m
Updated 1d ago
Share Price
n/a
1Y-83.1%
7D-4.2%
1D-2.4%
Portfolio Value
​
View

Inuvo, Inc.

DB:CD5 Stock Report

Market Cap: €8.3m

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Inuvo (CD5) Stock Overview

An advertising technology and services company, develops and commercializes large language generative artificial intelligence that discovers and targets digital audiences in the United States. More details

CD5 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Rewards

Earnings have grown 15.2% per year over the past 5 years

Trading at good value compared to peers and industry

Risk Analysis

Earnings are forecast to decline by an average of 35.1% per year for the next 3 years

Does not have a meaningful market cap (€8M)

Volatile share price over the past 3 months compared to the German market

Has less than 1 year of cash runway

+ 1 more risk

CD5 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW428,308 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
428,308 investors already sharing narratives
€
Current Price
€0.5025.7% undervalued intrinsic discount
%/yr
Decrease
Increase
PastFuture-15m98m2016201920222025202620282031Revenue US$14.4mEarnings US$1.7m
Advanced
View all narratives

Inuvo, Inc. Competitors

tick Trading Software

Symbol: BST:TBX0
Market cap: €11.9m

B+S Banksysteme

Symbol: XTRA:DTD2
Market cap: €11.6m

Swissnet

Symbol: XTRA:81D
Market cap: €13.3m

Solutiance

Symbol: XTRA:SLSA
Market cap: €8.7m

Price History & Performance

Summary of share price highs, lows and changes for Inuvo
Historical stock prices
Current Share PriceUS$0.50
52 Week HighUS$3.56
52 Week LowUS$0.48
Beta1.2
1 Month Change-19.68%
3 Month Change-57.07%
1 Year Change-83.06%
3 Year Change-74.72%
5 Year Change-91.56%
Change since IPO-97.58%

Recent News & Updates

Recent updates

Shareholder Returns

CD5DE SoftwareDE Market
7D-4.2%3.2%-1.1%
1Y-83.1%-20.4%3.3%

Return vs Industry: CD5 underperformed the German Software industry which returned -19.1% over the past year.

Return vs Market: CD5 underperformed the German Market which returned 4.7% over the past year.

Price Volatility

Is CD5's price volatile compared to industry and market?
CD5 volatility
CD5 Average Weekly Movement11.6%
Software Industry Average Movement5.9%
Market Average Movement4.9%
10% most volatile stocks in DE Market12.0%
10% least volatile stocks in DE Market2.5%

Stable Share Price: CD5's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: CD5's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
n/a51Rob Buchnerinuvo.com

Inuvo, Inc., an advertising technology and services company, develops and commercializes large language generative artificial intelligence that discovers and targets digital audiences in the United States. The company offers IntentKey, an artificial intelligence, data analytics, and automation tool that can optimize the purchase and placement of advertising in real time without consumer data, which can serve multiple creative formats including agencies and brands; CTV, video, audio, native, display channels; and platform. The company sells its information technology solutions to agencies, brands, and large consolidators of advertising demand.

Inuvo, Inc. Fundamentals Summary

How do Inuvo's earnings and revenue compare to its market cap?
CD5 fundamental statistics
Market cap€8.32m
Earnings (TTM)-€3.90m
Revenue (TTM)€45.53m
0.2x
P/S Ratio
-2.2x
P/E Ratio

Is CD5 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CD5 income statement (TTM)
RevenueUS$52.29m
Cost of RevenueUS$19.27m
Gross ProfitUS$33.02m
Other ExpensesUS$37.50m
Earnings-US$4.48m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-0.27
Gross Margin63.15%
Net Profit Margin-8.56%
Debt/Equity Ratio117.1%

How did CD5 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/18 21:21
End of Day Share Price 2026/09/18 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Inuvo, Inc. is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian KinstlingerAlliance Global Partners
Eric MartinuzziCraig-Hallum Capital Group LLC
Almas AlmaganbetovFreedom Broker

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide